Extreme Challenges - Psychopathology & Treatment Experiences Among Severly Selfharming Inpatients in Norway
NCT ID: NCT03768674
Last Updated: 2024-06-21
Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
COMPLETED
Total Enrollment
1640 participants
Study Classification
OBSERVATIONAL
Study Start Date
2019-10-01
Study Completion Date
2021-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients who self-harm are a heterogeneous population. Outpatient treatments structured for borderline personality disorder are often recommended and hospitalization kept to a minimum. However, few studies have focused on the most severe, complex conditions with extreme suicide risk. A recent national investigation from Norway (2017) demonstrated a far larger cohort of extensively hospitalized inpatients with extreme self-harming behaviors than was expected (N=427) - identified in all health regions. Reported challenges were high-risk situations, severe medical sequelae, difficult collaborations across services, and uncertainty about psychiatric diagnoses.
Severe, often bizarre, self-harm is thus a major challenge for both patients and health services. In hospitals, safety measures can involve restrictions and involuntary regimes. As research on this target population is sparse, the current project seeks further understanding of complex conditions - psychopathology, treatment experiences and service collaboration.
The project is a national, multi-center cooperation including patients in psychiatric hospitals in all health regions. It is cross sectional. Data is based on diagnostic interviews, patients' self-reported symptoms and both patients and service providers treatment experiences. The inclusion period for inpatients (N=300) and a comparison sample of outpatients (N=300) is one year.
The target group is inpatients with extreme hospitalization and severe self-mutilation. A comparison group is patients with personality pathology attending outpatient treatments. Recruitment is across health regions.
Aim 1: Investigate psychopathology of patients in the target population and compare to a clinical sample admitted to outpatient treatment
Aim 2: Investigate personality functioning in the target population and compare to a clinical sample admitted to outpatient treatment
Aim 3: a) Investigate health service use in the target population and compare to a clinical sample admitted to outpatient treatment.
b) Investigate treatment experiences and health service collaborations in the target population.
The project will provide rational for future preventive treatment interventions
Severe, often bizarre, self-harm is thus a major challenge for both patients and health services. In hospitals, safety measures can involve restrictions and involuntary regimes. As research on this target population is sparse, the current project seeks further understanding of complex conditions - psychopathology, treatment experiences and service collaboration.
The project is a national, multi-center cooperation including patients in psychiatric hospitals in all health regions. It is cross sectional. Data is based on diagnostic interviews, patients' self-reported symptoms and both patients and service providers treatment experiences. The inclusion period for inpatients (N=300) and a comparison sample of outpatients (N=300) is one year.
The target group is inpatients with extreme hospitalization and severe self-mutilation. A comparison group is patients with personality pathology attending outpatient treatments. Recruitment is across health regions.
Aim 1: Investigate psychopathology of patients in the target population and compare to a clinical sample admitted to outpatient treatment
Aim 2: Investigate personality functioning in the target population and compare to a clinical sample admitted to outpatient treatment
Aim 3: a) Investigate health service use in the target population and compare to a clinical sample admitted to outpatient treatment.
b) Investigate treatment experiences and health service collaborations in the target population.
The project will provide rational for future preventive treatment interventions
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Implementation of Family Involvement for Persons With Psychotic Disorders.
NCT03869177
Psychotic Disorders
COMPLETED
NA
Implementation of a Tool for Reduction of Cardiovascular Risk in Patients with Severe Mental Disorders ( HEALTHYHEART )
NCT06807242
Schizophrenic Psychoses
Schizophrenia
Severe Mental Disorder
COMPLETED
First Episode Psychosis and Pathway to Care in Nordland
NCT01753284
First Episode Psychosis
COMPLETED
Duration of Untreated Psychosis (DUP) and Pathways to Care in Nordland
NCT01196858
Schizophrenia and Disorders With Psychotic Features
Affective Psychosis, Bipolar
Psychoses
COMPLETED
Effects of Neurocognitive and Social Cognitive Remediation in Patients at Ultra-High Risk of Psychosis
NCT02098408
Patients at Ultra-high Risk of Psychosis
COMPLETED
NA
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Design: A cross-sectional investigation. The inclusion period will be one year.
The target group: Patients admitted to inpatient units (adult psychiatry, mental health centres or hospitals) due to risk of severe self-harm. The duration of admissions are either more than 4 weeks and/or patients have had more than five admissions in the preceding year.
The comparison group is a collaboration with the Norwegian Network of personality-focused treatments and includes clinical data from 19 outpatient units within specialist mental health services across Norway (baseline data for 300 patients admitted to treatment during 2017-2018).
Sample size: An inclusion of N=300 patients in the target Group and comparison group
Assessments: The assessment battery combines therapist administered interviews and patient self-report measures to provide a broad differential-diagnostic evaluation and information about treatment and health-service collaborations. It also includes therapist-reports.
Psychopathology: Assessment of psychiatric disorders includes interviews for symptom disorders (MINI), personality traits and disorders (SCID-5-PD, and observer-evaluated global functioning (GAF) administered in both the target and the comparison group. Assessment of the target group will additionally include a screening interview on cognitive functioning (Hayes Ability Screening Index, HASI, specific approval has been given), self-report screening of autism (Ritvo Autisme Asperger Diagnoseskjema - Revidert RAADS-R), and a detailed interview on psychosis (questions from MINI plus).
General, social and personality functioning: The assessment battery includes a combination of well-established, (no cost) self-report measures covering overall functioning, symptoms, trauma, personality functioning and maladaptive behaviors. These will be administered in both the target and the comparison group. More details on assessment battery can be given on request to PI.
Self-harming behaviors: Self-report on self-harming behaviors and suicide attempts last 6 months are included. Assessment of the target group will additionally include a more detailed interview of self-harming behaviors adapted for Norwegian studies (Lifetime Para suicide Count).
Service use, treatment experiences, and health service collaborations: Assessment of previous treatments, age first time, and contact with child/adolescent psychiatry (self-report, both the target and the comparison group), and a detailed interview on medication, treatments, primary health care and welfare services last 6 months (specially designed interview, both target and comparison group). In addition, for the target group, questions about involuntary and restrictive regimes, treatment involvement, confidence, alliance and collaboration within and across health services are included (patient and therapist reported).
Research collaborators:
The PhD candidate will follow the PhD educationary program at the University of Oslo. Main supervisor is also Principle Investigator (E.H.Kvarstein), and co supervisor (G.Pedersen) heads the Network collaboration. The PhD candidate will join the national project group and be an associated member of the Research group for Personality Psychiatry.
The national project group is central in all phases; design, preparations, implementation procedures, evaluation, and presentations of results. It covers all health regions, relevant research environments, clinicians and users. It includes: Middle HR: T.Torgersen, PhD, Western HR: T.Tveit, MD. Southeastern HR: P.A.Ringen, PhD, P.Danielsen, MA, C.A.Sveen (MA), Tore Buer (MD). Northern HR: H.Tvete, MD, T.Høifødt, PhD. National Centre, Suicide Research and Prevention: F.Walby,MA, R.K.Ramleth, MD (BUP). Regional Centre, Violence and Traumatic Stress: I.Lunde, MA. Early intervention Psychosis: K.L.Romm, PhD. Personality Psychiatry National Advisory Unit: Ø.Urnes,MD. User experience: T.Røstbakken, M.Pettersen, A.Holst.
The Research group for personality psychiatry (University of Oslo/Oslo University Hospital) is an active, well-established research group with engagement in national and international research collaborations specializing on personality pathology and clinical research.
The principle investigator (PI) and main supervisor of this project, E.H.Kvarstein, associate professor, University of Oslo/ Head senior consultant, Section for Personality Psychiatry, Oslo University Hospital, is head of the Research group of personality psychiatry.
The Norwegian Network for personality-focused treatment is a well-established collaboration aiming to ensure clinical quality, systematic treatment evaluation and generate data for clinical research (anonymous data collection). The Network was established in 1993 and currently includes 19 outpatient treatment teams across Norway for patients with personality disorder. Approximately 400 patients are admitted to treatments within the Network each year (mean treatment duration: 2 years). The Network provides systems for patient assessment and progress evaluation, systematic feedback reports on clinical outcomes and supervision/seminars on diagnostic assessment and treatment. The main (ongoing) research project in the Network is a multi-centre feasibility investigation of evidence-based treatment for personality disorder (started in 2017) aiming to include longitudinal treatment data for 500 patients.
"Extreme challenges" is a research collaboration between the national project group and the Network. Baseline data from the multi-centre project constitute the outpatient comparison group in "Extreme challenges" (300 patients, admitted to outpatient treatment in 2017-18, data available in 2020).
Cosupervisor in the PhD project, head of the Network, is senior researcher Geir Pedersen. He is affiliated within the Section for Personality Psychiatry, Oslo University Hospital and the University of Oslo. He is a member of the research group.
Norwegian National Advisory Unit on Personality Psychiatry (NAPP) is the initiator of the current project and the organizer of the national project group. With the establishment of an expert user panel (recruiting users from the whole country), NAPP has also had an active role establishing user engagement in this project.
Plan for activities - practical implementation of the cross sectional investigation: The national project group has already completed a preliminary screening investigation, first publication, and designed the current project. The project group is currently preparing practical implementation of the project (mobilizing regional collaborators, local resource groups and finalizing ethic approvals and systems for data collection).
2018/19: Preparation: Regional preparatory seminars for local clinicians and all collaborators are scheduled to autumn 2019.
2019/2020: Data collection: Assessments of the target population will be performed at the inpatient institutions by local clinicians qualified for diagnostic procedures. During the data collection possibilities for feedbacks/clinical discussion of individual cases will be offered.
Assessments in the comparison group involve measures already implemented (from June 2017).
2021: Dataanalysis, discussion and presentation of results: Datacollection will be concluded and analyses of results proceeds.
2022: Project conclusion
Plan for dissemination of results:
Running information about the project with Norwegian summaries, key researchers and references to all publications will be available at the internet home site of the Research group for Personality Psychiatry in all phases of the project.
Three research publications are scheduled. Manuscripts will be submitted to international peer reviewed journals (open access publication). Research results will also be presented in relevant international/national conferences
When the project is concluded, the project group will arrange a conference for participating clinicians/institutions/organizations, evaluating the investigation, implications and further developments.
User involvement:
The project-group includes three members with relevant user experience, Thea Røstbakken, Mona Pettersen and Andrea Holst.
Ethical considerations The regional ethical committee (REC) has approved the investigator's application for ethical approval. REC reference number is: 2018/1124 A (REC South East).
The target group: Patients admitted to inpatient units (adult psychiatry, mental health centres or hospitals) due to risk of severe self-harm. The duration of admissions are either more than 4 weeks and/or patients have had more than five admissions in the preceding year.
The comparison group is a collaboration with the Norwegian Network of personality-focused treatments and includes clinical data from 19 outpatient units within specialist mental health services across Norway (baseline data for 300 patients admitted to treatment during 2017-2018).
Sample size: An inclusion of N=300 patients in the target Group and comparison group
Assessments: The assessment battery combines therapist administered interviews and patient self-report measures to provide a broad differential-diagnostic evaluation and information about treatment and health-service collaborations. It also includes therapist-reports.
Psychopathology: Assessment of psychiatric disorders includes interviews for symptom disorders (MINI), personality traits and disorders (SCID-5-PD, and observer-evaluated global functioning (GAF) administered in both the target and the comparison group. Assessment of the target group will additionally include a screening interview on cognitive functioning (Hayes Ability Screening Index, HASI, specific approval has been given), self-report screening of autism (Ritvo Autisme Asperger Diagnoseskjema - Revidert RAADS-R), and a detailed interview on psychosis (questions from MINI plus).
General, social and personality functioning: The assessment battery includes a combination of well-established, (no cost) self-report measures covering overall functioning, symptoms, trauma, personality functioning and maladaptive behaviors. These will be administered in both the target and the comparison group. More details on assessment battery can be given on request to PI.
Self-harming behaviors: Self-report on self-harming behaviors and suicide attempts last 6 months are included. Assessment of the target group will additionally include a more detailed interview of self-harming behaviors adapted for Norwegian studies (Lifetime Para suicide Count).
Service use, treatment experiences, and health service collaborations: Assessment of previous treatments, age first time, and contact with child/adolescent psychiatry (self-report, both the target and the comparison group), and a detailed interview on medication, treatments, primary health care and welfare services last 6 months (specially designed interview, both target and comparison group). In addition, for the target group, questions about involuntary and restrictive regimes, treatment involvement, confidence, alliance and collaboration within and across health services are included (patient and therapist reported).
Research collaborators:
The PhD candidate will follow the PhD educationary program at the University of Oslo. Main supervisor is also Principle Investigator (E.H.Kvarstein), and co supervisor (G.Pedersen) heads the Network collaboration. The PhD candidate will join the national project group and be an associated member of the Research group for Personality Psychiatry.
The national project group is central in all phases; design, preparations, implementation procedures, evaluation, and presentations of results. It covers all health regions, relevant research environments, clinicians and users. It includes: Middle HR: T.Torgersen, PhD, Western HR: T.Tveit, MD. Southeastern HR: P.A.Ringen, PhD, P.Danielsen, MA, C.A.Sveen (MA), Tore Buer (MD). Northern HR: H.Tvete, MD, T.Høifødt, PhD. National Centre, Suicide Research and Prevention: F.Walby,MA, R.K.Ramleth, MD (BUP). Regional Centre, Violence and Traumatic Stress: I.Lunde, MA. Early intervention Psychosis: K.L.Romm, PhD. Personality Psychiatry National Advisory Unit: Ø.Urnes,MD. User experience: T.Røstbakken, M.Pettersen, A.Holst.
The Research group for personality psychiatry (University of Oslo/Oslo University Hospital) is an active, well-established research group with engagement in national and international research collaborations specializing on personality pathology and clinical research.
The principle investigator (PI) and main supervisor of this project, E.H.Kvarstein, associate professor, University of Oslo/ Head senior consultant, Section for Personality Psychiatry, Oslo University Hospital, is head of the Research group of personality psychiatry.
The Norwegian Network for personality-focused treatment is a well-established collaboration aiming to ensure clinical quality, systematic treatment evaluation and generate data for clinical research (anonymous data collection). The Network was established in 1993 and currently includes 19 outpatient treatment teams across Norway for patients with personality disorder. Approximately 400 patients are admitted to treatments within the Network each year (mean treatment duration: 2 years). The Network provides systems for patient assessment and progress evaluation, systematic feedback reports on clinical outcomes and supervision/seminars on diagnostic assessment and treatment. The main (ongoing) research project in the Network is a multi-centre feasibility investigation of evidence-based treatment for personality disorder (started in 2017) aiming to include longitudinal treatment data for 500 patients.
"Extreme challenges" is a research collaboration between the national project group and the Network. Baseline data from the multi-centre project constitute the outpatient comparison group in "Extreme challenges" (300 patients, admitted to outpatient treatment in 2017-18, data available in 2020).
Cosupervisor in the PhD project, head of the Network, is senior researcher Geir Pedersen. He is affiliated within the Section for Personality Psychiatry, Oslo University Hospital and the University of Oslo. He is a member of the research group.
Norwegian National Advisory Unit on Personality Psychiatry (NAPP) is the initiator of the current project and the organizer of the national project group. With the establishment of an expert user panel (recruiting users from the whole country), NAPP has also had an active role establishing user engagement in this project.
Plan for activities - practical implementation of the cross sectional investigation: The national project group has already completed a preliminary screening investigation, first publication, and designed the current project. The project group is currently preparing practical implementation of the project (mobilizing regional collaborators, local resource groups and finalizing ethic approvals and systems for data collection).
2018/19: Preparation: Regional preparatory seminars for local clinicians and all collaborators are scheduled to autumn 2019.
2019/2020: Data collection: Assessments of the target population will be performed at the inpatient institutions by local clinicians qualified for diagnostic procedures. During the data collection possibilities for feedbacks/clinical discussion of individual cases will be offered.
Assessments in the comparison group involve measures already implemented (from June 2017).
2021: Dataanalysis, discussion and presentation of results: Datacollection will be concluded and analyses of results proceeds.
2022: Project conclusion
Plan for dissemination of results:
Running information about the project with Norwegian summaries, key researchers and references to all publications will be available at the internet home site of the Research group for Personality Psychiatry in all phases of the project.
Three research publications are scheduled. Manuscripts will be submitted to international peer reviewed journals (open access publication). Research results will also be presented in relevant international/national conferences
When the project is concluded, the project group will arrange a conference for participating clinicians/institutions/organizations, evaluating the investigation, implications and further developments.
User involvement:
The project-group includes three members with relevant user experience, Thea Røstbakken, Mona Pettersen and Andrea Holst.
Ethical considerations The regional ethical committee (REC) has approved the investigator's application for ethical approval. REC reference number is: 2018/1124 A (REC South East).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Self Harm
Personality Disorders
Psychosis
Developmental Disorder
PTSD
Cognitive Impairment
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Observational Model Type
COHORT
Study Time Perspective
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Inpatient cohort (Target group)
Inpatient at mental health centre/ psychiatric hospital due to severe self-harm. Duration \> 4 weeks and/or \> five admissions last year.
Assessment of diagnoses, functioning and health services
Assessment of diagnoses, functioning and health services
Intervention Type
OTHER
Systematic differential diagnostics, assessment of psychosocial and personality functioning and treatment/ health services
Outpatient comparison cohort
Admitted to treatment within Norwegian Network of personality-focused treatment during 2017-2018.
Assessment of diagnoses, functioning and health services
Assessment of diagnoses, functioning and health services
Intervention Type
OTHER
Systematic differential diagnostics, assessment of psychosocial and personality functioning and treatment/ health services
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Assessment of diagnoses, functioning and health services
Systematic differential diagnostics, assessment of psychosocial and personality functioning and treatment/ health services
Intervention Type
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admitted to inpatient units (adult psychiatry, mental health centres or hospitals) due to risk of severe self-harm.
* Duration of admissions either \> 4 weeks and/or \> five admissions preceding year.
• Assessed for outpatient treatment within the outpatient Network
* Duration of admissions either \> 4 weeks and/or \> five admissions preceding year.
• Assessed for outpatient treatment within the outpatient Network
Exclusion Criteria
• Not inpatients at a psychiatric, adult (18-60 yrs) institution
• Assessed but not admitted to outpatient treatment within the Network
• Assessed but not admitted to outpatient treatment within the Network
Minimum Eligible Age
18 Years
Maximum Eligible Age
60 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Extrastiftelsen
OTHER
Sponsor Role
collaborator
National Advisory Unit for Personality Psychiatry (NAPP)
UNKNOWN
Sponsor Role
collaborator
Research Group Personality Psychiatry
UNKNOWN
Sponsor Role
collaborator
Network for personality-focused treatment
UNKNOWN
Sponsor Role
collaborator
National Centre for Suicide Research and Prevention (NSSF)
UNKNOWN
Sponsor Role
collaborator
Regional Centre for Violence and Traumatic Stress (RVTS)
UNKNOWN
Sponsor Role
collaborator
Regional Centre for Early Intervention Psychosis (TIPS SØrØst)
UNKNOWN
Sponsor Role
collaborator
Regional collaborators and users
UNKNOWN
Sponsor Role
collaborator
Oslo University Hospital
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elfrida H Kvarstein
Head senior consultant/Associate Professor
Responsibility Role
PRINCIPAL_INVESTIGATOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elfrida H Kvarstein, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
Oslo University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oslo University Hospital
Oslo, , Norway
Site Status
Countries
Review the countries where the study has at least one active or historical site.
Norway
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018/1124
Identifier Type: OTHER
Identifier Source: secondary_id
2019/FO244009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Implementation of National Guidelines for Treatment of Psychoses
NCT03271242
COMPLETED
Cognitive Remediation in Early Phase Psychosis
NCT01546467
UNKNOWN
NA
Anomalous Self-Experience in First Episode Psychosis - A Six-Year Follow-Up Study
NCT02321943
COMPLETED
Clinical Trial of Integrated Treatment Versus Standard Treatment in First Episode Psychosis
NCT00157313
UNKNOWN
NA
Norwegian Adult Mental Health Registry
NCT06115200
NOT_YET_RECRUITING
A Register Study of Effects Following Local Variation in Rates of Involuntary Care
NCT04655287
COMPLETED
Characterization of High-Level Cognitive Impairments in Patients With Neuropsychiatric Disorders
NCT07295652
RECRUITING
NA
Effects of Action-Based Cognitive Remediation on Substance Misuse in Early Phase Psychosis
NCT07056894
NOT_YET_RECRUITING
NA
Continued Early Intervention for Recent-onset Schizophrenia
NCT00184509
TERMINATED
PHASE3
Seven-step Phenomenological Psychotherapy for Self-disorder - a Pilot Study
NCT06597864
RECRUITING
NA
Acute Psychological Effects of High Intensity Exercise With Schizophrenia
NCT01310998
COMPLETED
NA
Exploration of the Social Cognition in Adolescents With a Dissociative Disorder or Autism Spectrum
NCT01805128
COMPLETED
NA
Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Cannabis Use and Cognitive Outcomes in Schizophrenia
NCT03189810
COMPLETED
NA
The Danish Region Midt Schizophrenia Cohort
NCT06431009
RECRUITING
Socio-cognitive and Biological Responses to Maltreatment
NCT07101107
NOT_YET_RECRUITING
Well Being And Resilience: Mechanisms of Transmission of Health and Risk
NCT02306551
COMPLETED
Brain Activation Patterns in Schizophrenia After Computerized Cognitive Skills Training
NCT00431223
COMPLETED
NA
Honest Open Proud for Psychotic and Bipolar Disorder in Norway
NCT06384755
RECRUITING
NA
Investigation of Change in The WHO-5 Well-Being Index During a Year in a Community Psychiatry in Denmark
NCT03501329
COMPLETED
Acute, Affective, Organic Disorders.
NCT00201474
COMPLETED
Service User and Staff Views on Digital Remote Monitoring for Psychosis
NCT05670197
COMPLETED
Impact of Cannabis Consumption on the Course, Modalities of Hospitalization and the Short-term Prognosis of Inpatients Suffering From Psychotic Symptoms
NCT06314204
RECRUITING
Goal Management Training for Patients With Schizophrenia or High Risk for Schizophrenia
NCT03048695
COMPLETED
NA
Non-Pharmacological Treatment of Psychosis
NCT04051775
UNKNOWN
CHALLENGE. A Randomised Clinical Trial Examining Virtual Reality Therapy
NCT04661163
COMPLETED
NA